Table IV.
Groups | Median | IQR | Differences from 21th daya |
---|---|---|---|
Sham (n=9) | 1.22 | 0.66 | Z=0.415; P=0.678 |
PCOS control (n=9) | 4.88 | 0.65 | Z=2.547; P=0.011 |
Merformin (n=8) | 1.67 | 0.36 | Z=2.521; P=0.012 |
Metformin + PDE4i (n=10) | 1.05 | 0.22 | Z=2.803; P=0.005 |
Wilcoxon signed rank test results. IQR, interquartile range; PCOS, polycystic ovary syndrome; PDE4i, phosphodiesterase 4 inhibitor.